Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection-Reference-Cited by-同舟云学术

Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection

Published:2012-10-02 Issue:1 Volume:15 Page:34-41
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Momper J.D.¹,Zhao Y.²,Shapiro R.³,Schonder K.S.⁴,Gao Y.²,Randhawa P.S.⁵,Venkataramanan R.

Affiliation:

1. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research; U.S. Food and Drug Administration; Silver Spring; Maryland; USA

2. Department of Pharmaceutical Sciences; University of Pittsburgh; Pittsburgh; Pennsylvania; USA

3. Department of Surgery; University of Pittsburgh; Pittsburgh; Pennsylvania; USA

4. Department of Pharmacy and Therapeutics, School of Pharmacy; University of Pittsburgh; Pittsburgh; Pennsylvania; USA

5. Department of Pathology, School of Medicine, Thomas E. Starzl Transplantation Institute; University of Pittsburgh; Pittsburgh; Pennsylvania; USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12014/fullpdf

Reference32 articles.

1. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game;Nickeleit;Nephrol Dial Transplant,2000

2. BK virus infection in a kidney allograft diagnosed by needle biopsy;Purighalla;Am J Kidney Dis,1995

3. Clinical course of polyoma virus nephropathy in 67 renal transplant patients;Ramos;J Am Soc Nephrol,2002

4. Human polyoma virus-associated interstitial nephritis in the allograft kidney;Randhawa;Transplantation,1999

5. BK virus infection in transplant recipients: an overview and update;Randhawa;Am J Transplant,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy;Transplant Infectious Disease;2024-09-03

2. Drug Resistance in Skin Diseases;Biochemistry of Drug Resistance;2021

3. Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing;Transplantation Direct;2020-05-28

4. Combination therapy as an effective tool for treatment of drug-resistant viral infections;Combination Therapy Against Multidrug Resistance;2020

5. Antiviral treatment of BK virus viremia after kidney transplantation;American Journal of Health-System Pharmacy;2017-12-15